Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 293
6
Diseases
8
Unique genes
0.258
Avg. similarity score
Ataxia with vitamin e deficiency
Most-connected disease (5 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Ataxia with vitamin e deficiency
Aapoai amyloidosis
Apolipoprotein a-i amyloidosis
Apolipoprotein a-i deficiency
Hypoalphalipoproteinemia
Vitamin e deficiency
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Ataxia with vitamin e deficiency | 5 | 5 | 3 |
| Aapoai amyloidosis | 4 | 4 | 1 |
| Apolipoprotein a-i amyloidosis | 4 | 4 | 1 |
| Apolipoprotein a-i deficiency | 4 | 4 | 2 |
| Hypoalphalipoproteinemia | 4 | 4 | 7 |
| Vitamin e deficiency | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| APOA1 | 5 / 6 | Aapoai amyloidosis, Apolipoprotein a-i amyloidosis, Apolipoprotein a-i deficiency, Ataxia with vitamin e deficiency and 1 more |
| ABCA1 | 2 / 6 | Apolipoprotein a-i deficiency, Hypoalphalipoproteinemia |
| APOB | 2 / 6 | Ataxia with vitamin e deficiency, Hypoalphalipoproteinemia |
| TTPA | 2 / 6 | Ataxia with vitamin e deficiency, Vitamin e deficiency |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Cholesterol metabolism | KEGG | 5 / 51 | 147× | 6.26e-11 | 9.37e-9 ✓ sig. |
| Defective ABCA1 causes Tangier disease | Reactome | 2 / 2 | 1,501× | 3.88e-7 | 2.15e-5 ✓ sig. |
| Fat digestion and absorption | KEGG | 3 / 43 | 105× | 2.36e-6 | 1.02e-4 ✓ sig. |
| Scavenging by Class B Receptors | Reactome | 2 / 5 | 601× | 3.88e-6 | 1.55e-4 ✓ sig. |
| HDL assembly | Reactome | 2 / 8 | 375× | 1.08e-5 | 3.59e-4 ✓ sig. |
| Chylomicron remodeling | Reactome | 2 / 9 | 334× | 1.39e-5 | 4.42e-4 ✓ sig. |
| Chylomicron assembly | Reactome | 2 / 9 | 334× | 1.39e-5 | 4.42e-4 ✓ sig. |
| Scavenging by Class A Receptors | Reactome | 2 / 11 | 273× | 2.13e-5 | 6.29e-4 ✓ sig. |
| Post-translational protein phosphorylation | Reactome | 3 / 108 | 41.7× | 3.83e-5 | 1.03e-3 ✓ sig. |
| LDL clearance | Reactome | 2 / 18 | 167× | 5.91e-5 | 1.46e-3 ✓ sig. |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | Reactome | 3 / 125 | 36.0× | 5.93e-5 | 1.47e-3 ✓ sig. |
| Vitamin digestion and absorption | KEGG | 2 / 26 | 115× | 1.25e-4 | 2.69e-3 ✓ sig. |
| Lipid and atherosclerosis | KEGG | 3 / 216 | 20.9× | 3.01e-4 | 5.37e-3 ✓ sig. |
| Retinoid metabolism and transport | Reactome | 2 / 41 | 73.2× | 3.14e-4 | 5.56e-3 ✓ sig. |
| Vitamin E | Reactome | 1 / 1 | 1,501× | 6.66e-4 | 9.96e-3 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| lipoprotein metabolic process | GO:0042157 | 4 / 26 | 359× | 2.05e-10 | 5.46e-8 ✓ sig. |
| cholesterol metabolic process | GO:0008203 | 5 / 107 | 109× | 3.09e-10 | 7.87e-8 ✓ sig. |
| cholesterol homeostasis | GO:0042632 | 5 / 112 | 104× | 3.90e-10 | 9.61e-8 ✓ sig. |
| lipoprotein biosynthetic process | GO:0042158 | 3 / 6 | 1,168× | 1.03e-9 | 2.29e-7 ✓ sig. |
| phospholipid homeostasis | GO:0055091 | 3 / 17 | 412× | 3.49e-8 | 5.00e-6 ✓ sig. |
| cholesterol transport | GO:0030301 | 3 / 28 | 250× | 1.68e-7 | 1.87e-5 ✓ sig. |
| steroid metabolic process | GO:0008202 | 4 / 135 | 69.2× | 1.78e-7 | 1.96e-5 ✓ sig. |
| lipid metabolic process | GO:0006629 | 6 / 840 | 16.7× | 2.10e-7 | 2.26e-5 ✓ sig. |
| cholesterol efflux | GO:0033344 | 3 / 31 | 226× | 2.30e-7 | 2.44e-5 ✓ sig. |
| acylglycerol homeostasis | GO:0055090 | 2 / 5 | 934× | 1.60e-6 | 1.21e-4 ✓ sig. |
| cellular response to lipoprotein particle stimulus | GO:0071402 | 2 / 5 | 934× | 1.60e-6 | 1.21e-4 ✓ sig. |
| phospholipid metabolic process | GO:0006644 | 3 / 66 | 106× | 2.33e-6 | 1.63e-4 ✓ sig. |
| negative regulation of very-low-density lipoprotein particle remodeling | GO:0010903 | 2 / 6 | 779× | 2.40e-6 | 1.67e-4 ✓ sig. |
| high-density lipoprotein particle assembly | GO:0034380 | 2 / 10 | 467× | 7.20e-6 | 4.02e-4 ✓ sig. |
| vitamin transport | GO:0051180 | 2 / 10 | 467× | 7.20e-6 | 4.02e-4 ✓ sig. |